As of 2025-05-16, the Fair Value of CASI Pharmaceuticals Inc (CASI) is -8.85 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.81 USD, the upside of CASI Pharmaceuticals Inc is -589.14%.
With the market price of 1.81 USD and our fair value calculation, CASI Pharmaceuticals Inc (CASI) is not a good investment. Investing in CASI stocks now will result in a potential loss of 589.14%.
Note: valuation result may not be accurate due to the low predictability of business.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 5Y Avg | |
| Net income | -27.47 | -44.97 | -46.59 | -35.14 | -31.52 | -37.14 |
| YoY growth | -155.06% | -63.71% | -3.60% | 24.58% | 10.30% | -37.50% |
| Market Cap (mil) | 28.04 |
| P/E | |
| Forward P/E |
| EPS | -1.77 |
| Avg earnings growth rate | -37.50% |
| TTM earnings |